Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. on August 17, 2016. The report discloses a material event regarding the company's business operations and market access.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a strategic business event rather than financial performance data.
Material Changes
On August 17, 2016, Trovagene, Inc. signed an in-network provider agreement with Blue Cross Blue Shield of Illinois (BCBSIL). This agreement establishes health benefit access for the full line of the Company's tests and services within the BCBSIL network.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the context of the new agreement. The primary disclosure is the execution of the provider contract.
Investor Verification Checklist
- Verify the terms and effective date of the in-network agreement with Blue Cross Blue Shield of Illinois.
- Confirm the scope of tests and services covered under the new agreement.
- Review the full text of the press release furnished as Exhibit 99.1 for additional details.